|
|
| (150 intermediate revisions by 19 users not shown) |
| label / nl | label / nl |
| | | Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer |
| label / ast | label / ast |
| | | Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer |
| description / nl | description / nl |
| | | wetenschappelijk artikel (gepubliceerd op 13.06.2013) |
| description / cs | description / cs |
| | | vědecký článek publikovaný v roce 2013 |
| description / fr | description / fr |
| | | article scientifique (publié 2013/06/13) |
| description / it | description / it |
| | | articolo scientifico (pubblicato il 2013/06/13) |
| description / sk | description / sk |
| | | vedecký článok (publikovaný 2013/06/13) |
| description / da | description / da |
| | | videnskabelig artikel (udgivet 2013/06/13) |
| description / pt | description / pt |
| | | artigo científico (publicado na 2013/06/13) |
| description / hy | description / hy |
| | | 2013 թվականի հունիսին հրատարակված գիտական հոդված |
| description / ar | description / ar |
| | | مقالة علمية (نشرت في 13-6-2013) |
| description / pt-br | description / pt-br |
| | | artigo científico (publicado na 2013) |
| description / sr | description / sr |
| | | научни чланак |
| description / hu | description / hu |
| | | tudományos cikk |
| description / tr | description / tr |
| | | bilimsel makale |
| description / tg | description / tg |
| | | мақолаи илмӣ |
| description / ja | description / ja |
| | | 2013年の論文 |
| description / bn | description / bn |
| | | ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ |
| description / gl | description / gl |
| | | artigo científico |
| description / sr-el | description / sr-el |
| | | naučni članak |
| description / el | description / el |
| | | επιστημονικό άρθρο |
| description / sv | description / sv |
| | | vetenskaplig artikel |
| description / et | description / et |
| | | teaduslik artikkel |
| description / yue | description / yue |
| | | 2013年論文 |
| description / es | description / es |
| | | artículo científico publicado en 2013 |
| description / zh-cn | description / zh-cn |
| | | 2013年论文 |
| description / zh-my | description / zh-my |
| | | 2013年论文 |
| description / pl | description / pl |
| | | artykuł naukowy |
| description / zh-hans | description / zh-hans |
| | | 2013年论文 |
| description / uk | description / uk |
| | | наукова стаття, опублікована в червні 2013 |
| description / sq | description / sq |
| | | artikull shkencor |
| description / de | description / de |
| | | wissenschaftlicher Artikel |
| description / ast | description / ast |
| | | artículu científicu espublizáu en 2013 |
| description / ka | description / ka |
| | | სამეცნიერო სტატია |
| description / nan | description / nan |
| | | 2013 nî lūn-bûn |
| description / zh-hant | description / zh-hant |
| | | 2013年論文 |
| description / zh-mo | description / zh-mo |
| | | 2013年論文 |
| description / vi | description / vi |
| | | bài báo khoa học |
| description / nb | description / nb |
| | | vitenskapelig artikkel |
| description / tl | description / tl |
| | | artikulong pang-agham |
| description / th | description / th |
| | | บทความทางวิทยาศาสตร์ |
| description / nn | description / nn |
| | | vitskapeleg artikkel |
| description / ru | description / ru |
| | | научная статья |
| description / fi | description / fi |
| | | tieteellinen artikkeli |
| description / he | description / he |
| | | מאמר מדעי |
| description / zh-tw | description / zh-tw |
| | | 2013年論文 |
| description / ca | description / ca |
| | | article científic |
| description / tg-cyrl | description / tg-cyrl |
| | | мақолаи илмӣ |
| description / sr-ec | description / sr-ec |
| | | научни чланак |
| description / zh-hk | description / zh-hk |
| | | 2013年論文 |
| description / eo | description / eo |
| | | scienca artikolo |
| description / bg | description / bg |
| | | научна статия |
| description / wuu | description / wuu |
| | | 2013年论文 |
| description / zh | description / zh |
| | | 2013年论文 |
| description / lt | description / lt |
| | | mokslinis straipsnis |
| description / zh-sg | description / zh-sg |
| | | 2013年论文 |
| description / ro | description / ro |
| | | articol științific |
| description / oc | description / oc |
| | | article scientific |
| description / ko | description / ko |
| | | 2013년 논문 |
| description / hyw | description / hyw |
| | | 2013 թուականի Յունիսին հրատարակուած գիտական յօդուած |
| description / fa | description / fa |
| | | مقالهٔ علمی |
| description / ur | description / ur |
| | | سائنسی مضمون |
| description / ml | description / ml |
| | | 2013 ജൂണ് 13 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം |
| Property / PubMed publication ID: 23763830 / reference |
| | | |
| Property / PubMed publication ID: 23763830 / reference | |
| | |
| Property / DOI: 10.1186/1479-5876-11-147 / reference |
| | | |
| Property / DOI: 10.1186/1479-5876-11-147 / reference | |
| | |
| Property / PMC publication ID: 3683338 / reference |
| | | |
| Property / PMC publication ID: 3683338 / reference | |
| | |
| Property / publication date: 13 June 2013 / reference |
| | | |
| Property / publication date: 13 June 2013 / reference |
| | | |
| Property / publication date: 13 June 2013 / reference |
| | | |
| Property / publication date: 13 June 2013 / reference |
| | | |
| Property / publication date: 13 June 2013 / reference |
| | | |
| Property / publication date: 13 June 2013 / reference |
| | | |
| Property / original language of film or TV show | |
| | |
| Property / original language of film or TV show: English / rank | |
| Normal rank
| |
| Property / original language of film or TV show: English / reference | |
| | |
| Property / author name string: Jean Levêque / qualifier |
| | | |
| Property / instance of |
| | | |
| Property / instance of: review article / rank |
| | | Normal rank |
| Property / instance of: review article / reference |
| | | stated in: PubMed
retrieved: 27 October 2020| Timestamp | +2020-10-27T00:00:00Z |
|---|
| Timezone | +00:00 |
|---|
| Calendar | Gregorian |
|---|
| Precision | 1 day |
|---|
| Before | 0 |
|---|
| After | 0 |
|---|
|
| Property / author name string |
| | | Fabrice Foucher |
| Property / author name string: Fabrice Foucher / rank |
| | | Normal rank |
| Property / author name string: Fabrice Foucher / qualifier |
| | | |
| Property / author name string: Fabrice Foucher / reference |
| | | |
| Property / author name string |
| | | Sébastien Henno |
| Property / author name string: Sébastien Henno / rank |
| | | Normal rank |
| Property / author name string: Sébastien Henno / qualifier |
| | | |
| Property / author name string: Sébastien Henno / reference |
| | | |
| Property / author name string |
| | | Vincent Jauffret |
| Property / author name string: Vincent Jauffret / rank |
| | | Normal rank |
| Property / author name string: Vincent Jauffret / qualifier |
| | | |
| Property / author name string: Vincent Jauffret / reference |
| | | |
| Property / author name string |
| | | Veronique Catros |
| Property / author name string: Veronique Catros / rank |
| | | Normal rank |
| Property / author name string: Veronique Catros / qualifier |
| | | |
| Property / author name string: Veronique Catros / reference |
| | | |
| Property / author name string |
| | | Florian Cabillic |
| Property / author name string: Florian Cabillic / rank |
| | | Normal rank |
| Property / author name string: Florian Cabillic / qualifier |
| | | |
| Property / author name string: Florian Cabillic / reference |
| | | |
| Property / published in |
| | | |
| Property / published in: Journal of Translational Medicine / rank |
| | | Normal rank |
| Property / published in: Journal of Translational Medicine / reference |
| | | |
| Property / published in: Journal of Translational Medicine / reference |
| | | |
| Property / published in: Journal of Translational Medicine / reference |
| | | |
| Property / published in: Journal of Translational Medicine / reference |
| | | |
| Property / published in: Journal of Translational Medicine / reference |
| | | |
| Property / published in: Journal of Translational Medicine / reference |
| | | |
| Property / published in: Journal of Translational Medicine / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Suppression, subversion and escape: the role of regulatory T cells in cancer progression / rank |
| | | Normal rank |
| Property / cites work: Suppression, subversion and escape: the role of regulatory T cells in cancer progression / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer / rank |
| | | Normal rank |
| Property / cites work: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial / rank |
| | | Normal rank |
| Property / cites work: The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antigen-specific active immunotherapy for ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Antigen-specific active immunotherapy for ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: T helper 17 cells promote cytotoxic T cell activation in tumor immunity / rank |
| | | Normal rank |
| Property / cites work: T helper 17 cells promote cytotoxic T cell activation in tumor immunity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma / rank |
| | | Normal rank |
| Property / cites work: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow / rank |
| | | Normal rank |
| Property / cites work: ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC) / rank |
| | | Normal rank |
| Property / cites work: Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC) / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells / rank |
| | | Normal rank |
| Property / cites work: B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer / rank |
| | | Normal rank |
| Property / cites work: Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion / rank |
| | | Normal rank |
| Property / cites work: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion / rank |
| | | Normal rank |
| Property / cites work: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Celecoxib for the prevention of colorectal adenomatous polyps / rank |
| | | Normal rank |
| Property / cites work: Celecoxib for the prevention of colorectal adenomatous polyps / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? / rank |
| | | Normal rank |
| Property / cites work: Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Cancer statistics, 2009 / rank |
| | | Normal rank |
| Property / cites work: Cancer statistics, 2009 / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival / rank |
| | | Normal rank |
| Property / cites work: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tolerogenic dendritic cells / rank |
| | | Normal rank |
| Property / cites work: Tolerogenic dendritic cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients. / rank |
| | | Normal rank |
| Property / cites work: A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The basic principles of chimeric antigen receptor design / rank |
| | | Normal rank |
| Property / cites work: The basic principles of chimeric antigen receptor design / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination. / rank |
| | | Normal rank |
| Property / cites work: Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy / rank |
| | | Normal rank |
| Property / cites work: Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction / rank |
| | | Normal rank |
| Property / cites work: PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Human Th17 cells in patients with cancer: Friends or foe? / rank |
| | | Normal rank |
| Property / cites work: Human Th17 cells in patients with cancer: Friends or foe? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion / rank |
| | | Normal rank |
| Property / cites work: Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma / rank |
| | | Normal rank |
| Property / cites work: A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance. / rank |
| | | Normal rank |
| Property / cites work: Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity / rank |
| | | Normal rank |
| Property / cites work: Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells / rank |
| | | Normal rank |
| Property / cites work: Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients / rank |
| | | Normal rank |
| Property / cites work: CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. / rank |
| | | Normal rank |
| Property / cites work: Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents / rank |
| | | Normal rank |
| Property / cites work: ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Ovarian cancer progression is controlled by phenotypic changes in dendritic cells / rank |
| | | Normal rank |
| Property / cites work: Ovarian cancer progression is controlled by phenotypic changes in dendritic cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression / rank |
| | | Normal rank |
| Property / cites work: Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions / rank |
| | | Normal rank |
| Property / cites work: Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy / rank |
| | | Normal rank |
| Property / cites work: Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment / rank |
| | | Normal rank |
| Property / cites work: PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumour macrophages as potential targets of bisphosphonates. / rank |
| | | Normal rank |
| Property / cites work: Tumour macrophages as potential targets of bisphosphonates. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules / rank |
| | | Normal rank |
| Property / cites work: Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. / rank |
| | | Normal rank |
| Property / cites work: Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antigen-presenting cell (APC) subsets in ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Antigen-presenting cell (APC) subsets in ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Immunity and immune suppression in human ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Immunity and immune suppression in human ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy / rank |
| | | Normal rank |
| Property / cites work: Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Immune parameters affecting the efficacy of chemotherapeutic regimens / rank |
| | | Normal rank |
| Property / cites work: Immune parameters affecting the efficacy of chemotherapeutic regimens / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Th17 cells in cancer: help or hindrance? / rank |
| | | Normal rank |
| Property / cites work: Th17 cells in cancer: help or hindrance? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion / rank |
| | | Normal rank |
| Property / cites work: Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Immunotherapy for ovarian cancer: what's next? / rank |
| | | Normal rank |
| Property / cites work: Immunotherapy for ovarian cancer: what's next? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function / rank |
| | | Normal rank |
| Property / cites work: COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma / rank |
| | | Normal rank |
| Property / cites work: Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes / rank |
| | | Normal rank |
| Property / cites work: Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling / rank |
| | | Normal rank |
| Property / cites work: PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines / rank |
| | | Normal rank |
| Property / cites work: Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice / rank |
| | | Normal rank |
| Property / cites work: Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells / rank |
| | | Normal rank |
| Property / cites work: MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes / rank |
| | | Normal rank |
| Property / cites work: Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer / rank |
| | | Normal rank |
| Property / cites work: Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes / rank |
| | | Normal rank |
| Property / cites work: Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression. / rank |
| | | Normal rank |
| Property / cites work: Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival / rank |
| | | Normal rank |
| Property / cites work: Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans / rank |
| | | Normal rank |
| Property / cites work: The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells / rank |
| | | Normal rank |
| Property / cites work: In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma / rank |
| | | Normal rank |
| Property / cites work: Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors / rank |
| | | Normal rank |
| Property / cites work: Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies / rank |
| | | Normal rank |
| Property / cites work: Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments / rank |
| | | Normal rank |
| Property / cites work: Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery / rank |
| | | Normal rank |
| Property / cites work: Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Chemokine receptors as targets for cancer therapy / rank |
| | | Normal rank |
| Property / cites work: Chemokine receptors as targets for cancer therapy / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer. / rank |
| | | Normal rank |
| Property / cites work: Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression / rank |
| | | Normal rank |
| Property / cites work: Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells / rank |
| | | Normal rank |
| Property / cites work: Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Immunogenic cancer cell death: a key-lock paradigm / rank |
| | | Normal rank |
| Property / cites work: Immunogenic cancer cell death: a key-lock paradigm / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The anticancer immune response: indispensable for therapeutic success? / rank |
| | | Normal rank |
| Property / cites work: The anticancer immune response: indispensable for therapeutic success? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma / rank |
| | | Normal rank |
| Property / cites work: HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. / rank |
| | | Normal rank |
| Property / cites work: Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma / rank |
| | | Normal rank |
| Property / cites work: Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The impact of T-cell immunity on ovarian cancer outcomes / rank |
| | | Normal rank |
| Property / cites work: The impact of T-cell immunity on ovarian cancer outcomes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients / rank |
| | | Normal rank |
| Property / cites work: Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. / rank |
| | | Normal rank |
| Property / cites work: Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Creating immune privilege: active local suppression that benefits friends, but protects foes. / rank |
| | | Normal rank |
| Property / cites work: Creating immune privilege: active local suppression that benefits friends, but protects foes. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study / rank |
| | | Normal rank |
| Property / cites work: Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. / rank |
| | | Normal rank |
| Property / cites work: Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer / rank |
| | | Normal rank |
| Property / cites work: Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta / rank |
| | | Normal rank |
| Property / cites work: Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells / rank |
| | | Normal rank |
| Property / cites work: Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients / rank |
| | | Normal rank |
| Property / cites work: All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells / rank |
| | | Normal rank |
| Property / cites work: CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Management of platinum-sensitive recurrent ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Management of platinum-sensitive recurrent ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses / rank |
| | | Normal rank |
| Property / cites work: Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death / rank |
| | | Normal rank |
| Property / cites work: Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Regulatory T cells in ovarian cancer: biology and therapeutic potential / rank |
| | | Normal rank |
| Property / cites work: Regulatory T cells in ovarian cancer: biology and therapeutic potential / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma / rank |
| | | Normal rank |
| Property / cites work: Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells / rank |
| | | Normal rank |
| Property / cites work: Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells / rank |
| | | Normal rank |
| Property / cites work: Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Functional diversity and plasticity of human dendritic cell subsets / rank |
| | | Normal rank |
| Property / cites work: Functional diversity and plasticity of human dendritic cell subsets / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas / rank |
| | | Normal rank |
| Property / cites work: Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. / rank |
| | | Normal rank |
| Property / cites work: Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Immunologic principles and immunotherapeutic approaches in ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Immunologic principles and immunotherapeutic approaches in ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity / rank |
| | | Normal rank |
| Property / cites work: Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. / rank |
| | | Normal rank |
| Property / cites work: TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. / rank |
| | | Normal rank |
| Property / cites work: Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells / rank |
| | | Normal rank |
| Property / cites work: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses / rank |
| | | Normal rank |
| Property / cites work: Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells / rank |
| | | Normal rank |
| Property / cites work: Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity / rank |
| | | Normal rank |
| Property / cites work: Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes / rank |
| | | Normal rank |
| Property / cites work: Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Distinct mechanisms of immunosuppression as a consequence of major surgery / rank |
| | | Normal rank |
| Property / cites work: Distinct mechanisms of immunosuppression as a consequence of major surgery / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The concept of immunological surveillance / rank |
| | | Normal rank |
| Property / cites work: The concept of immunological surveillance / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves / rank |
| | | Normal rank |
| Property / cites work: Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma / rank |
| | | Normal rank |
| Property / cites work: Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial / rank |
| | | Normal rank |
| Property / cites work: Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery / rank |
| | | Normal rank |
| Property / cites work: Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial. / rank |
| | | Normal rank |
| Property / cites work: Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene / rank |
| | | Normal rank |
| Property / cites work: Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel / rank |
| | | Normal rank |
| Property / cites work: Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer. / rank |
| | | Normal rank |
| Property / cites work: Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group / rank |
| | | Normal rank |
| Property / cites work: HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. / rank |
| | | Normal rank |
| Property / cites work: Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma / rank |
| | | Normal rank |
| Property / cites work: Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. / rank |
| | | Normal rank |
| Property / cites work: Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. / rank |
| | | Normal rank |
| Property / cites work: The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. / rank |
| | | Normal rank |
| Property / cites work: ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host / rank |
| | | Normal rank |
| Property / cites work: Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma / rank |
| | | Normal rank |
| Property / cites work: Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. / rank |
| | | Normal rank |
| Property / cites work: Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. / rank |
| | | Normal rank |
| Property / cites work: GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A critique of surgical cytoreduction in advanced ovarian cancer. / rank |
| | | Normal rank |
| Property / cites work: A critique of surgical cytoreduction in advanced ovarian cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Cellular immunity in breast cancer patients completing taxane treatment / rank |
| | | Normal rank |
| Property / cites work: Cellular immunity in breast cancer patients completing taxane treatment / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II). / rank |
| | | Normal rank |
| Property / cites work: Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II). / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study / rank |
| | | Normal rank |
| Property / cites work: Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. / rank |
| | | Normal rank |
| Property / cites work: Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial / rank |
| | | Normal rank |
| Property / cites work: Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Induction of T cell responses against autologous ovarian tumors with whole tumor cell lysate-pulsed dendritic cells / rank |
| | | Normal rank |
| Property / cites work: Induction of T cell responses against autologous ovarian tumors with whole tumor cell lysate-pulsed dendritic cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients / rank |
| | | Normal rank |
| Property / cites work: Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. / rank |
| | | Normal rank |
| Property / cites work: A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity / rank |
| | | Normal rank |
| Property / cites work: Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer / rank |
| | | Normal rank |
| Property / cites work: Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells / rank |
| | | Normal rank |
| Property / cites work: The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. / rank |
| | | Normal rank |
| Property / cites work: NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: [Prognostic significance of tumor-associated macrophage infiltration in advanced epithelial ovarian carcinoma] / rank |
| | | Normal rank |
| Property / cites work: [Prognostic significance of tumor-associated macrophage infiltration in advanced epithelial ovarian carcinoma] / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) / rank |
| | | Normal rank |
| Property / cites work: Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR / rank |
| | | Normal rank |
| Property / cites work: The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma / rank |
| | | Normal rank |
| Property / cites work: Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide / rank |
| | | Normal rank |
| Property / cites work: Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Natural killer cell activity and progression-free survival in ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Natural killer cell activity and progression-free survival in ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group / rank |
| | | Normal rank |
| Property / cites work: Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta / rank |
| | | Normal rank |
| Property / cites work: Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines / rank |
| | | Normal rank |
| Property / cites work: Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor vaccine for ovarian carcinoma targeting sperm protein 17 / rank |
| | | Normal rank |
| Property / cites work: Tumor vaccine for ovarian carcinoma targeting sperm protein 17 / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: T-cell recognition of ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: T-cell recognition of ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides / rank |
| | | Normal rank |
| Property / cites work: Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss / rank |
| | | Normal rank |
| Property / cites work: Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer / rank |
| | | Normal rank |
| Property / cites work: Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma / rank |
| | | Normal rank |
| Property / cites work: Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs / rank |
| | | Normal rank |
| Property / cites work: TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission / rank |
| | | Normal rank |
| Property / cites work: A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells / rank |
| | | Normal rank |
| Property / cites work: Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Soluble HLA-G molecules are increased in lymphoproliferative disorders / rank |
| | | Normal rank |
| Property / cites work: Soluble HLA-G molecules are increased in lymphoproliferative disorders / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function / rank |
| | | Normal rank |
| Property / cites work: The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function / reference |
| | | |
| Property / OpenCitations bibliographic resource ID |
| | | |
| Property / OpenCitations bibliographic resource ID: 2062909 / rank |
| | | Normal rank |
| Property / OpenCitations bibliographic resource ID: 2062909 / reference |
| | | |
| Property / author |
| | | |
| Property / author: Marc-Antoine Belaud-Rotureau / rank |
| | | Normal rank |
| Property / author: Marc-Antoine Belaud-Rotureau / qualifier |
| | | |
| Property / author: Marc-Antoine Belaud-Rotureau / qualifier |
| | | |
| Property / author: Marc-Antoine Belaud-Rotureau / reference |
| | | |
| Property / language of work or name |
| | | |
| Property / language of work or name: English / rank |
| | | Normal rank |
| Property / language of work or name: English / reference |
| | | |
| Property / ResearchGate publication ID |
| | | |
| Property / ResearchGate publication ID: 237819387 / rank |
| | | Normal rank |
| Property / copyright license |
| | | |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / rank |
| | | Normal rank |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / reference |
| | | |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / reference |
| | | |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / reference |
| | | |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / reference |
| | | |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / reference |
| | | |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / reference |
| | | |
| Property / copyright license: Creative Commons Attribution 2.0 Generic / reference |
| | | |
| Property / main subject |
| | | |
| Property / main subject: carcinoma / rank |
| | | Normal rank |
| Property / main subject: carcinoma / reference |
| | | stated in: PubMed
retrieved: 27 October 2020| Timestamp | +2020-10-27T00:00:00Z |
|---|
| Timezone | +00:00 |
|---|
| Calendar | Gregorian |
|---|
| Precision | 1 day |
|---|
| Before | 0 |
|---|
| After | 0 |
|---|
|
| Property / main subject |
| | | |
| Property / main subject: ovarian neoplasm / rank |
| | | Normal rank |
| Property / main subject: ovarian neoplasm / reference |
| | | |
| Property / main subject: ovarian neoplasm / reference |
| | | stated in: PubMed
retrieved: 27 October 2020| Timestamp | +2020-10-27T00:00:00Z |
|---|
| Timezone | +00:00 |
|---|
| Calendar | Gregorian |
|---|
| Precision | 1 day |
|---|
| Before | 0 |
|---|
| After | 0 |
|---|
|
| Property / main subject |
| | | |
| Property / main subject: immune tolerance / rank |
| | | Normal rank |
| Property / main subject: immune tolerance / reference |
| | | |
| Property / main subject: immune tolerance / reference |
| | | stated in: PubMed
retrieved: 27 October 2020| Timestamp | +2020-10-27T00:00:00Z |
|---|
| Timezone | +00:00 |
|---|
| Calendar | Gregorian |
|---|
| Precision | 1 day |
|---|
| Before | 0 |
|---|
| After | 0 |
|---|
|
| Property / main subject |
| | | |
| Property / main subject: glandular and epithelial neoplasm / rank |
| | | Normal rank |
| Property / main subject: glandular and epithelial neoplasm / reference |
| | | stated in: PubMed
retrieved: 27 October 2020| Timestamp | +2020-10-27T00:00:00Z |
|---|
| Timezone | +00:00 |
|---|
| Calendar | Gregorian |
|---|
| Precision | 1 day |
|---|
| Before | 0 |
|---|
| After | 0 |
|---|
|
| Property / main subject |
| | | |
| Property / main subject: ovarian carcinoma / rank |
| | | Normal rank |
| Property / main subject: ovarian carcinoma / reference |
| | | |
| Property / on focus list of Wikimedia project |
| | | |
| Property / on focus list of Wikimedia project: ScienceSource / rank |
| | | Normal rank |
| Property / Dimensions Publication ID |
| | | |
| Property / Dimensions Publication ID: 1010308538 / rank |
| | | Normal rank |
| Property / Dimensions Publication ID: 1010308538 / reference |
| | | |
| Property / copyright status |
| | | |
| Property / copyright status: copyrighted / rank |
| | | Normal rank |